A 64-year-old woman with a mechanical mitral valve prosthesis developed late-onset Candida endocarditis. Blood cultures grew Candida glabrata and Candida krusei. Transesophageal echocardiography demonstrated vegetations on the valve. The patient was not medically fit for valve replacement, but her condition was successfully treated with 6 weeks of intravenous caspofungin therapy.
30 s, and she had a hemoglobin level of 7.7 g/dL, a WBC count of 15.6 ϫ 10 9 cells/L, and a C reactive protein level of 128 mg/ L. The albumin level was 24 g/L, the creatine kinase level was 7292 IU/L, and the aspartate transaminase level was 3053 IU/ L, but the bilirubin, alkaline phosphatase, and gamma-glutamyl transferase levels were normal. A large left-calf hematoma was confirmed by ultrasonography and was managed conservatively. CT scans revealed a right pleural effusion, bibasal atelectasis, a small amount of ascites, and blood within the colon. Esophagogastroduodenoscopy revealed mild gastric erosions, which were treated with lansoprazole therapy.
Although the patient was not febrile at admission, sepsis was considered in the differential diagnosis. Blood for culture was obtained, and intravenous cefuroxime and metronidazole therapy was started empirically. The abdominal pain and vomiting subsided with conservative management. However, 24 h after the patient was admitted to the hospital, her body temperature began to spike to 138ЊC, and additional blood for culture was obtained.
The blood cultures performed on the day after the patient was admitted to the hospital in the United Kingdom yielded a Candida species after 5 days of incubation. Additional blood for culture was obtained, and intravenous fluconazole therapy was initiated. Three days later, the initial isolate had been identified as Candida glabrata, and the cultures of blood obtained 6 days after admission also yielded a Candida species. The MICs for the C. glabrata isolate were as follows: fluconazole, 32 mg/ L; itraconazole, 4 mg/L; voriconazole, 1 mg/L; flucytosine, Transesophageal echocardiography revealed multiple, small, mobile vegetations on the atrial aspect of the mechanical mitral valve ring (figure 1) and a small paraprosthetic leak. Using Duke clinical criteria [1] , we diagnosed definite endocarditis on the basis of 1 major criterion (an echocardiogram finding positive for endocarditis) and 3 minor criteria (fever; predisposition; and a positive blood culture result not satisfying the major criteria). At this stage, the patient was not medically fit for valve replacement, and therefore the therapeutic strategy was to attempt cure with drug therapy alone.
One week later, the bilirubin level rose to 40 mg/L, and the alkaline phosphatase level rose to 230 IU/L, but the aspartate transaminase level had improved to 60 IU/L. Acute hepatitis C virus (HCV) infection was determined by detection of HCV RNA and a subsequent rise in the level of hepatitis C antibodies. Hepatitis B virus and HIV serologic test results were negative. The source of HCV was presumed to be the blood transfusions the patient had received in Nigeria.
Two days later, the patient experienced further abdominal pain and distension and vomiting similar to that seen at presentation, and clinical examination suggested peritonitis. An abdominal CT scan showed free air and fluid within the peritoneal cavity. Emergency laparotomy was performed; a section of perforated necrotic small bowel was excised, and a defunctioning ileostomy was formed. Histological examination of the resected small-bowel tissue revealed evidence of cytomegalovirus ileitis, with mucosal ulceration and ischemia.
After treatment with caspofungin was started, blood culture results were negative. Caspofungin therapy was stopped after 6 weeks. No other antifungal agents were used. A transesophageal echocardiogram, performed 3 weeks later, demonstrated complete resolution of the vegetations. There was no growth on several sets of blood cultures performed after the caspofungin therapy was stopped, including cultures performed 10 months after the completion of treatment.
The patient underwent prolonged rehabilitation and was discharged from the hospital after 4 months. Six months after discharge, she remained healthy and underwent reversal of the ileostomy.
Discussion. Candida species are an uncommon but increasing cause of infective endocarditis, accounting for 1%-6% of cases [2] . The increasing incidence of fungal endocarditis over the past 20 years has been ascribed to changes in drug therapy and surgical techniques. The use of prosthetic devices, long-term intravenous catheters, broad-spectrum antibiotics, and immunosuppressiion are all risk factors for Candida endocarditis [2] [3] [4] [5] .
Candida endocarditis has a crude mortality rate of 150%, despite treatment [2, 3] . The disease often occurs in patients with multiple comorbidities, so the attributable mortality is difficult to assess. Optimal management of the disease requires a high index of suspicion and the prompt use of appropriate antifungal agents [2, 3, 6] . Valve replacement combined with drug therapy is thought to offer an improved outcome, especially when a prosthetic valve is affected. However, there is no evidence from clinical trials to support this practice.
In this case, both C. glabrata and C. krusei were isolated from blood cultures, which suggests that the endocarditis was caused by 2 different Candida species. Although uncommon, polymicrobial Candida endocarditis has been reported previously [2, 3] . The source of the infection in our patient was unclear, but intravascular devices placed in the patient at the Nigerian hospital or the colitic bowel may have been involved.
Antifungal resistance among Candida species is uncommon [6] [7] [8] [9] . However, C. krusei and C. glabrata may express intrinsic resistance and acquired resistance, respectively, to fluconazole, and they may also be less susceptible to amphotericin B [6, 8, 10, 11] . Thus, there is a need for other systemically active agents with fungicidal activity against drug-resistant strains.
Caspofungin is an echinocandin with potent fungicidal activity against many species of Candida [11, 12] . Caspofungin has been shown to be as effective as and less toxic than amphotericin B in the treatment of invasive candidiasis [13] . Caspofungin and other echinocandins have been shown to exhibit potent in vitro activity against fluconazole-resistant Candida species [12, 14, 15] . To our knowledge, the present report is the first description of successful treatment of Candida prosthetic valve endocarditis with caspofungin therapy alone.
Summary. We describe a case of Candida endocarditis involving a mechanical prosthetic mitral valve successfully treated with caspofungin therapy alone. Although valve replacement is generally recommended for cases of Candida prosthetic valve endocarditis, valve replacement was not required for cure in this case. Caspofungin has potent fungicidal activity against many species of Candida [16, 17] , including those resistant to other antifungals, and it is less toxic than amphotericin B. In certain cases, successful treatment of Candida prosthetic valve endocarditis may be achievable by use of caspofungin therapy alone. Caspofungin may be of benefit in the treatment of Candida prosthetic valve endocarditis for patients who are not medically fit for valve replacement, particularly if either C. glabrata or C. krusei are isolated.
